JPMORGAN CHASE & CO - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 36 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2019$304,000
-0.3%
333,0000.0%0.00%
Q2 2019$305,000
-1.0%
333,0000.0%0.00%
Q1 2019$308,000
+2.3%
333,0000.0%0.00%
Q4 2018$301,000
-3.5%
333,0000.0%0.00%
Q3 2018$312,000
-98.9%
333,000
-98.9%
0.00%
-100.0%
Q3 2017$28,128,000
-43.6%
31,212,000
-32.7%
0.01%
-45.5%
Q2 2017$49,856,000
+44.3%
46,347,000
+43.5%
0.01%
+37.5%
Q1 2017$34,544,000
+422.1%
32,298,000
+434.9%
0.01%
+300.0%
Q4 2016$6,616,000
-11.0%
6,038,000
-3.3%
0.00%0.0%
Q3 2016$7,433,000
+2.0%
6,243,000
+7.7%
0.00%0.0%
Q2 2016$7,284,000
-1.8%
5,798,000
+1.8%
0.00%0.0%
Q1 2016$7,419,000
-13.0%
5,696,000
+4.9%
0.00%0.0%
Q4 2015$8,529,000
-2.2%
5,432,000
-15.3%
0.00%0.0%
Q3 2015$8,718,000
+30.0%
6,416,000
+33.7%
0.00%0.0%
Q2 2015$6,706,000
-5.5%
4,799,000
+0.0%
0.00%0.0%
Q1 2015$7,100,000
+12.8%
4,797,000
+4.1%
0.00%
+100.0%
Q4 2014$6,293,000
-14.9%
4,606,000
-20.0%
0.00%
-50.0%
Q3 2014$7,396,000
+5.9%
5,761,000
+5.4%
0.00%0.0%
Q2 2014$6,984,000
+122.5%
5,464,000
+120.9%
0.00%
+100.0%
Q1 2014$3,139,000
+19.5%
2,473,0000.0%0.00%0.0%
Q4 2013$2,626,000
+1.8%
2,473,000
-0.6%
0.00%0.0%
Q3 2013$2,579,000
-80.2%
2,487,000
-80.0%
0.00%
-75.0%
Q2 2013$13,015,00012,425,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2013
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders